Organization · Venture Capital
SV Health Investors
SV Health Investors is a healthcare-focused venture capital and growth equity firm based in Boston and London. With over 30 years of experience, it specializes in investing across various healthcare sectors, including biotechnology and medtech.
Overview
What SV Health Investors does
What SV Health Investors is
SV Health Investors is a healthcare-focused venture capital and growth equity firm based in Boston and London. With over 30 years of experience, it specializes in investing across various healthcare sectors, including biotechnology and medtech.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 1993
- Approximate age
- About 33 years
- Structured capabilities
- Funder
- Last reviewed
- April 26, 2026
Official channels
Find SV Health Investors elsewhere
Open the official website or a supported primary organization account.
Capability profile
SV Health Investors as a funder
Investment thesis
SV Health Investors focuses on healthcare investments through dedicated funds targeting biotechnology, healthcare growth equity, and medtech. They invest in companies developing precision medicines and innovative therapeutics, particularly for dementia, while also supporting healthcare services and digital health.
Focus narrative
The firm invests across multiple sectors within healthcare, including biotechnology, healthcare growth equity, and medtech. Their strategy encompasses early to late-stage investments, particularly in companies developing precision medicines and innovative therapeutics for dementia, as well as providing growth capital for healthcare services and digital health companies.
Value beyond capital
SV Health Investors adds value to its portfolio companies by providing strategic guidance, access to a broad network of industry contacts, and expertise in navigating the healthcare landscape. Their dedicated focus on healthcare allows them to support companies in achieving their growth objectives effectively.
Focus and fit
- Stages
- Friends and Family · Angel · Pre-seed · Seed · Seed+ · Series A · Series A+ · Series B · Series B+ · Series C · Series C+ · Series D · Series E · Series F · Growth Equity · Pre-IPO · Ipo · Secondary · Bridge · Recap
- Regions
- Global · North America · Europe · Uk
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded notable exits
- EpiVax and EyeBio
Portfolio context
Notable portfolio companies include: Quell Therapeutics: Developing CAR-Treg therapies. QurAlis: Focused on precision medicine for sporadic ALS. Alector: Innovating therapeutics in neuroscience. Achillion Pharmaceuticals: Specializing in treatments for infectious diseases. American Well: A telehealth platform offering virtual care solutions.
Common questions
What to know about SV Health Investors
Upseed classifies SV Health Investors under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 26, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.